Data MATRIX to Offer Free EDC for All COVID-19 Trials
Data MATRIX, an eClinical software developer, has announced free access to its proprietary EDC system for sponsors running COVID-19 trials in 2020.
Recognizing the latest update of the World Health Organization with the total count of people diagnosed with coronavirus surpassing 200,000 over 8,000 of whom died, Data MATRIX’s team could not overlook the urgency which calls for the highest level of productivity and proficiency from the global life sciences community.
In response to the global outbreak of the pandemic the clinical data management software developer will provide its validated SaaS solution for clinical trials at zero cost for researchers to be able to obtain clean data and speed up the trials of such a vital value to the global community.
Given that timeline is of the highest value when dealing with pandemic, Data MATRIX EDC will provide researchers with the essential resources enabling immediate project start-up and deployment.
“During these times it is essential for everyone to practice compassion and humanity. We encourage businesses of various industries to pool their efforts and resources and do all they can in helping to combat the pandemic. We are more than happy to support researchers looking for a COVID-19 vaccine. Therefore, we are honored to provide our solutions to all the researchers and healthcare colleagues around the world to stop this unprecedented global threat. We want to step in simply because we can,” said Data MATRIX Founder, Dmitry Sharov.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
